BPC-157 / GHK-Cu / KPV / TB-500.
A comprehensive four-peptide protocol covering recovery, inflammation, and connective-tissue regeneration.
3 mg / 10 mg / 3 mg / 3 mg per mL · single-vial injectablePricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients with complex or multi-system recovery needs
- Post-surgical recovery where skin, soft tissue, and inflammation all matter
- Patients wanting one comprehensive nightly protocol
- Patients who haven't fully responded to two- or three-peptide protocols
This isn't for you if
Investigational combination. Components have been subject to ongoing FDA regulatory review. Not appropriate during pregnancy, breastfeeding, or with active malignancy.
BPC-157 / GHK-Cu / KPV / TB-500
This four-peptide combination is the most comprehensive single-vial recovery and regenerative protocol in the catalog. It layers all four research mechanisms — tissue repair, collagen synthesis, inflammation modulation, and cell migration — in one nightly injection.
Mechanism and fit.
Each peptide addresses a different failure point in the healing process. BPC-157 reduces inflammation and supports tissue repair pathways. TB-500 enhances circulation and cellular migration in slow-healing tissues. GHK-Cu drives collagen and elastin production for skin and connective tissue. KPV calms the inflammatory signaling that interferes with healing. Together, the combination is designed to address every stage of recovery at once.
Who this is typically for.
- Patients with complex or multi-system recovery needs
- Post-surgical recovery where skin, soft tissue, and inflammation all matter
- Patients wanting one comprehensive nightly protocol
- Patients who haven't fully responded to two- or three-peptide protocols
What patients
most often ask.
Why would I choose this over the three-peptide version?
The four-peptide version adds KPV's anti-inflammatory action. It's the right choice when inflammation is a clear part of your clinical picture — gut, skin, autoimmune-adjacent, or systemic — alongside structural recovery needs.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients with complex or multi-system recovery needs</li><li>Post-surgical recovery where skin, soft tissue, and inflammation all matter</li><li>Patients wanting one comprehensive nightly protocol</li><li>Patients who haven't fully responded to two- or three-peptide protocols</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingOnce daily, provider-directed.
- Typical duration6–12 weeks per cycle, depending on complexity.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering BPC-157 / GHK-Cu / KPV / TB-500, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.